NASDAQ
ALX Oncology Holdings Inc. (ALXO) has a current ratio of 2.07x as of Monday, May 25, 2026. This represents a 82.06% decrease compared to its 12-month average of 11.52x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.